Johnson & Johnson offers $6.475 billion settlement for talc lawsuits

Johnson & Johnson offers $6.475 billion settlement for talc lawsuits

In a landmark move, Johnson & Johnson proposed a $6.475 billion (Rs 48,562.5 crore approximately) settlement to address the avalanche of lawsuits linking their talc-based products to ovarian cancer. Nearly 99% of the 54,000 consolidated cases allege ovarian cancer, prompting the company to seek resolution through a subsidiary firm's bankruptcy filing.